Skip to main content
Medical information Clinical review pending

Genetic Testing

WNT3 Gene Tetraamelia Autosomal Recessive Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to analyze the WNT3 gene for mutations associated with Tetraamelia, a rare congenital condition affecting limb development. Helps in early diagnosis and management, particularly for pediatric patients.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube) or saliva sample. Confirm specific requirements with the laboratory before collection.
Results
Results are typically available within 3 to 4 weeks. Confirm exact turnaround time with the laboratory before booking.
Preparation
No specific patient preparation is required. A clinical history and family pedigree chart are recommended to aid interpretation. Discuss any specific instructions with your doctor or the laboratory.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the WNT3 Gene Tetraamelia Autosomal Recessive Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Children with suspected Tetraamelia syndrome.
  • ✓Individuals presenting with congenital limb malformations.
  • ✓Family history of Tetraamelia or related genetic disorders.
  • ✓Prenatal diagnosis in high-risk pregnancies (Confirm with the laboratory).
  • ✓Genetic counseling for families affected by Tetraamelia.
02

In plain language

What this test helps you understand

This test helps identify specific mutations in the WNT3 gene associated with Tetraamelia syndrome, a rare congenital disorder affecting limb development. It aids in confirming a diagnosis, understanding the genetic basis of the condition, and guiding management strategies.
The WNT3 Gene Tetraamelia Autosomal Recessive NGS Genetic DNA Test is an advanced diagnostic tool used to identify genetic mutations linked to Tetraamelia syndrome. This rare condition is characterized by the absence or severe underdevelopment of limbs present at birth. This test is particularly important for families where a child shows signs of limb malformations or other congenital anomalies.

Utilizing Next-Generation Sequencing (NGS) technology, this test specifically examines the WNT3 gene. Detecting mutations in this gene can provide crucial information about the genetic cause of the condition, aiding healthcare providers in understanding the underlying factors.

This test is recommended for children presenting with symptoms suggestive of Tetraamelia or related limb development issues. It is also beneficial for individuals with a family history of Tetraamelia or similar genetic disorders. Early diagnosis allows for appropriate medical management and access to support services. Understanding the genetic basis can also inform decisions regarding future family planning.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. A clinical history and family pedigree chart are recommended to aid interpretation. Discuss any specific instructions with your doctor or the laboratory.
SampleBlood sample (EDTA tube) or saliva sample. Confirm specific requirements with the laboratory before collection.
MethodologyNext-Generation Sequencing (NGS) is used to analyze the WNT3 gene for pathogenic variants.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific regions of the WNT3 gene. It may not detect all possible mutations, such as deep intronic changes or large deletions/duplications not detectable by NGS. A negative result does not completely rule out a genetic cause for the condition. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Tetraamelia syndrome is a rare congenital condition characterized by the absence or severe underdevelopment of limbs present at birth.
This test is recommended for children with suspected Tetraamelia, individuals with congenital limb malformations, or those with a family history of the condition.
The test involves analyzing a sample of your blood or saliva to look for specific genetic mutations in the WNT3 gene using Next-Generation Sequencing (NGS).
A genetic counselor will help interpret the results and discuss their implications for the patient and family.
Yes, a convenient home sample collection service is available. Please contact the laboratory for details.
Results are typically available within 3 to 4 weeks, but confirm the exact turnaround time with the laboratory.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp